Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Erectile dysfunction in the cardiac patient.

Robert A Kloner1

  • 1Heart Institute, Good Samaritan Hospital, 1225 Wilshire Boulevard, Los Angeles, CA 90017, USA. rkloner@goodsam.org

Current Urology Reports
|November 19, 2003
PubMed
Summary

Erectile dysfunction (ED) is linked to vascular disease and shares risk factors with coronary artery disease. Phosphodiesterase-5 (PDE-5) inhibitors offer safe and effective oral therapy for ED, but are contraindicated with organic nitrates.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Longevity.

Clinical medicine & research·2026
Same author

Comparing incidence of heart failure in individuals with enlarged cardiac chambers versus diabetes.

American journal of preventive cardiology·2026
Same author

AI-CVD-HF: A heart failure risk prediction model based on coronary artery calcium scans compared with PREVENT-HF.

American journal of preventive cardiology·2026
Same author

Organ-Specific Efficacy of Postischemic Empagliflozin in Acute Stroke and Myocardial Infarction Using Preclinical Models.

Journal of the American Heart Association·2026
Same author

Sex Differences in the Adverse Effects of Nicotine-Free E-Cigarettes on Myocardial Oxygen Supply and Demand Balance: A Preclinical Rat Study.

Journal of the American Heart Association·2026
Same author

AI-Derived LA Volume Index, LA/RA and LA/LV Volume Ratios From Coronary Artery Calcium Scans Predict Long-Term Atrial Fibrillation and Stroke.

Stroke·2026

Area of Science:

  • Cardiovascular Medicine
  • Urology
  • Pharmacology

Background:

  • Erectile dysfunction (ED) frequently stems from endothelial dysfunction, signaling potential systemic vascular disease.
  • Shared risk factors for ED and coronary artery disease include lipid abnormalities, smoking, diabetes, and hypertension.

Purpose of the Study:

  • To review the role of endothelial dysfunction in ED.
  • To discuss the efficacy and safety of oral phosphodiesterase-5 (PDE-5) inhibitors for ED treatment.
  • To highlight contraindications for PDE-5 inhibitors, particularly with organic nitrates.

Main Methods:

  • Review of existing literature on ED, endothelial dysfunction, and PDE-5 inhibitors.
  • Analysis of pharmacological mechanisms of PDE-5 inhibitors.
  • Examination of clinical trial data regarding safety and efficacy.

Main Results:

  • PDE-5 inhibitors effectively treat ED by inhibiting PDE-5 and preserving cyclic guanosine monophosphate.
  • These agents are generally safe and effective for ED therapy.
  • Contraindication exists for patients concurrently using organic nitrates.

Conclusions:

  • ED is a significant indicator of underlying vascular health.
  • PDE-5 inhibitors represent a key therapeutic option for ED.
  • Careful patient selection and management are crucial, especially regarding nitrate use.

Related Experiment Videos